Hepatotoxicity and efficacy associated with first- and new-generation EGFR-TKIs in patients with NSCLC: a systematic review and meta-analysis. Wang Z, Meng J, Liu G, Wang Y, et al. BMC Cancer 2025;25:1909.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Z, Meng J, Liu G, Wang Y, et al. Hepatotoxicity and efficacy associated with first- and new-generation EGFR-TKIs in patients with NSCLC: a systematic review and meta-analysis. BMC Cancer 2025;25:1909.
PMID: 41462168